These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 9876236)

  • 1. The immune-endocrine loop during aging: role of growth hormone and insulin-like growth factor-I.
    Burgess W; Liu Q; Zhou J; Tang Q; Ozawa A; VanHoy R; Arkins S; Dantzer R; Kelley KW
    Neuroimmunomodulation; 1999; 6(1-2):56-68. PubMed ID: 9876236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Control of the thymic microenvironment by growth hormone/insulin-like growth factor-I-mediated circuits.
    Savino W; de Mello-Coelho V; Dardenne M
    Neuroimmunomodulation; 1995; 2(6):313-8. PubMed ID: 8840333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth hormone, growth factors and hematopoiesis.
    Kelley KW; Arkins S; Minshall C; Liu Q; Dantzer R
    Horm Res; 1996; 45(1-2):38-45. PubMed ID: 8742117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin growth factor-I inhibits apoptosis in hematopoietic progenitor cells. Implications in thymic aging.
    Kelley KW; Meier WA; Minshall C; Schacher DH; Liu Q; VanHoy R; Burgess W; Dantzer R
    Ann N Y Acad Sci; 1998 May; 840():518-24. PubMed ID: 9629278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphatidylinositol 3'-kinase, but not S6-kinase, is required for insulin-like growth factor-I and IL-4 to maintain expression of Bcl-2 and promote survival of myeloid progenitors.
    Minshall C; Arkins S; Dantzer R; Freund GG; Kelley KW
    J Immunol; 1999 Apr; 162(8):4542-9. PubMed ID: 10201993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of prolactin and growth hormone on thymus physiology.
    De Mello-Coelho V; Savino W; Postel-Vinay MC; Dardenne M
    Dev Immunol; 1998; 6(3-4):317-23. PubMed ID: 9814605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The thymus gland: a target organ for growth hormone.
    Savino W; Postel-Vinay MC; Smaniotto S; Dardenne M
    Scand J Immunol; 2002 May; 55(5):442-52. PubMed ID: 11975755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreases in growth hormone receptor signal transduction contribute to the decline in insulin-like growth factor I gene expression with age.
    Xu X; Bennett SA; Ingram RL; Sonntag WE
    Endocrinology; 1995 Oct; 136(10):4551-7. PubMed ID: 7664676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The proliferative and antiapoptotic actions of growth hormone and insulin-like growth factor-1 are mediated through distinct signaling pathways in the Pro-B Ba/F3 cell line.
    Baixeras E; Jeay S; Kelly PA; Postel-Vinay MC
    Endocrinology; 2001 Jul; 142(7):2968-77. PubMed ID: 11416018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insights into a role of GH secretagogues in reversing the age-related decline in the GH/IGF-I axis.
    Frutos MG; Cacicedo L; Fernández C; Vicent D; Velasco B; Zapatero H; Sánchez-Franco F
    Am J Physiol Endocrinol Metab; 2007 Nov; 293(5):E1140-52. PubMed ID: 17684105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age-dependent impairment of endothelial progenitor cells is corrected by growth-hormone-mediated increase of insulin-like growth-factor-1.
    Thum T; Hoeber S; Froese S; Klink I; Stichtenoth DO; Galuppo P; Jakob M; Tsikas D; Anker SD; Poole-Wilson PA; Borlak J; Ertl G; Bauersachs J
    Circ Res; 2007 Feb; 100(3):434-43. PubMed ID: 17234973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Requirement for phosphatidylinositol 3'-kinase to protect hemopoietic progenitors against apoptosis depends upon the extracellular survival factor.
    Minshall C; Arkins S; Freund GG; Kelley KW
    J Immunol; 1996 Feb; 156(3):939-47. PubMed ID: 8558020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Signal transduction through the IL-4 and insulin receptor families.
    Wang LM; Keegan A; Frankel M; Paul WE; Pierce JH
    Stem Cells; 1995 Jul; 13(4):360-8. PubMed ID: 7549895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of phosphatidylinositol 3'-kinase by insulin-like growth factor-I rescues promyeloid cells from apoptosis and permits their differentiation into granulocytes.
    Liu Q; Schacher D; Hurth C; Freund GG; Dantzer R; Kelley KW
    J Immunol; 1997 Jul; 159(2):829-37. PubMed ID: 9218601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The haematopoietic effects of growth hormone and insulin-like growth factor-I.
    Merchav S
    J Pediatr Endocrinol Metab; 1998; 11(6):677-85. PubMed ID: 9829220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of the growth hormone/insulin-like growth factor axis during Balb/c thymus ontogeny and effects of growth hormone upon ex vivo T cell differentiation.
    Kermani H; Goffinet L; Mottet M; Bodart G; Morrhaye G; Dardenne O; Renard C; Overbergh L; Baron F; Beguin Y; Geenen V; Martens HJ
    Neuroimmunomodulation; 2012; 19(3):137-47. PubMed ID: 22261974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physical and functional interaction of growth hormone and insulin-like growth factor-I signaling elements.
    Huang Y; Kim SO; Yang N; Jiang J; Frank SJ
    Mol Endocrinol; 2004 Jun; 18(6):1471-85. PubMed ID: 15044591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin-like growth factor-1 rescues the mutated FGF receptor 3 (G380R) expressing ATDC5 cells from apoptosis through phosphatidylinositol 3-kinase and MAPK.
    Koike M; Yamanaka Y; Inoue M; Tanaka H; Nishimura R; Seino Y
    J Bone Miner Res; 2003 Nov; 18(11):2043-51. PubMed ID: 14606518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of insulin-like growth factor administration and bone marrow transplantation on thymopoiesis in aged mice.
    Montecino-Rodriguez E; Clark R; Dorshkind K
    Endocrinology; 1998 Oct; 139(10):4120-6. PubMed ID: 9751491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells.
    Bartucci M; Morelli C; Mauro L; Andò S; Surmacz E
    Cancer Res; 2001 Sep; 61(18):6747-54. PubMed ID: 11559546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.